What are the major opportunities in the Asthma Drugs market? What are the strategies for the Asthma Drugs market?

For detailed insights on the major opportunities and strategies in the Asthma Drugs market, Read More

How does the Asthma Drugs market relate to the overall economy and other similar markets?

For detailed insights on Asthma Drugs's relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Asthma Drugs industry?

For detailed insights on the mergers and acquisitions in the Asthma Drugs industry, Read More

What are the key dynamics influencing the Asthma Drugs market growth? SWOT analysis of the Asthma Drugs market.

For detailed insights on the key dynamics influencing the Asthma Drugs market growth and SWOT analysis of the Asthma Drugs industry, Read More

Item added to cart!

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Asthma Drugs Global Market Report 2025

Name: Asthma Drugs Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type Of Asthma (Allergic, Non-Allergic), By Asthma Trigger Type (Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma), By Therapy (Preventive, Curative), By Drug Class (Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs), By End-User (Asthma Patients, COPD Patients) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Asthma Drugs Market Overview

• Asthma Drugs market size has reached to $23.96 billion in 2024

• Expected to grow to $31.38 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%

• Growth Driver: Soaring Prevalence Of Asthmatic Disorders Propels Growth In The Asthma Drug Market

• Market Trend: Glenmark Launches Indamet FDC Drug For Uncontrolled Asthma Treatment

• North America was the largest region in 2024 and Asia Pacific is the fastest growing region.

What Is Covered Under Asthma Drugs Market?

Asthma refers to a chronic lung disease that is caused by the inflammation and tightening of muscles around the airways, which makes patients suffer from effective breathing. This is caused when the airways get narrow, swollen, and blocked by excess mucus. Asthma drugs play a crucial role in managing asthma.

The main types of asthma are Allergic and non-allergic. Allergic asthma is a respiratory condition characterized by the constriction of airways upon exposure to an allergen, leading to difficulty in breathing. These are various trigger types for asthma such as adult-onset asthma, child-onset asthma, cough-induced asthma, exercise-induced asthma, occupational asthma, nocturnal asthma, and steroid-resistant asthma. Asthma drug are classified into classes such as bronchodilators, monoclonal antibodies, anti-inflammatory drugs, and combination drugs that are used by asthma patients and COPD patients.

Asthma Drugs Market Size and growth rate 2025 to 2029: Graph

What Is The Asthma Drugs Market Size 2025 And Growth Rate?

The asthma drugs market size has grown strongly in recent years. It will grow from $23.96 billion in 2024 to $24.93 billion in 2025 at a compound annual growth rate (CAGR) of 4.0%. The growth in the historic period can be attributed to environmental factors, increased respiratory disorders, lifestyle changes, healthcare infrastructure development

What Is The Asthma Drugs Market Growth Forecast?

The asthma drugs market size is expected to see strong growth in the next few years. It will grow to $31.38 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to rising air pollution levels, growing aging population, increasing healthcare awareness, personalized medicine trends, biopharmaceutical innovations. Major trends in the forecast period include small molecule therapies, home-based asthma care, biomarker-guided therapies, therapeutic advances in severe asthma, collaborations for asthma research.

The forecast of 5.9% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. allergy clinics by driving up costs of inhaled corticosteroid and long-acting beta2-agonist combination inhalers imported from Spain and Switzerland, exacerbating severe asthma management expenses and increasing respiratory care burdens for chronic patients. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Asthma Drugs Market Segmented?

1) By Type Of Asthma: Allergic, Non-Allergic

2) By Asthma Trigger Type: Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma

3) By Therapy: Preventive, Curative

4) By Drug Class: Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs

5) By End-User: Asthma Patients, COPD Patients

Subsegments:

1) By Allergic: Inhaled Corticosteroids (ICS), Leukotriene Receptor Antagonists (LTRAs), Monoclonal Antibodies

2) By Non-Allergic: Short-Acting Beta Agonists (SABAs), Long-Acting Beta Agonists (LABAs), Oral Corticosteroids

What Is Driving The Asthma Drugs Market? Soaring Prevalence Of Asthmatic Disorders Propels Growth In The Asthma Drug Market

The high prevalence of asthmatic disorders is expected to propel the growth of the asthma drug market going forward. Asthma refers to a long-term disease that causes inflammation and swelling of the airways, resulting in the narrowing of the airways that carry air from the nose and mouth to the lungs. Owing to the increase in asthma cases, there has been a surge in the identification of new asthma drugs for treating asthmatic disorders. For instance, in April 2024, according to the Asthma + Lung UK, an England-based charity that supports people with lung conditions, in 2021, the number of asthma-related deaths in England was recorded at 1,146, and this figure saw an increase in 2022, rising to 1,236, reflecting a concerning upward trend in fatalities associated with the condition over the course of the year.

What Is Driving The Asthma Drugs Market? Rising Prevalence Of Respiratory Diseases Fuels Growth In The Asthma Drug Market

The rising prevalence of respiratory diseases will boost the asthma drug market. Respiratory diseases are medical conditions that affect the respiratory system, which includes the lungs, bronchi, trachea, larynx, pharynx, and nasal passages. The prevalence of respiratory diseases drives the use of asthma drugs to manage and alleviate symptoms associated with respiratory conditions. As respiratory diseases become more widespread, particularly conditions like asthma characterized by chronic inflammation and airway constriction, the demand for effective therapeutic interventions increases. For instance, in September 2024, according to the American Lung Association, a US-based Professional organizations, in 2023, over 35 million people in the U.S. are living with a chronic lung condition such as asthma or COPD. Approximately 11.7 million adults, or 4.6% of the population, have been diagnosed with COPD, which includes chronic bronchitis and emphysema. Therefore, the rising prevalence of respiratory diseases will drive the asthma drug industry forward.

Who Are The Major Players In The Global Asthma Drugs Market?

Major companies operating in the asthma drugs market include Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC., GlaxoSmithKline PLC., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Novartis International AG, Mylan N.V., Cipla Limited, Chiesi Farmaceutici S.p.A., Sun Pharmaceutical Industries Limited, Hikma Pharmaceuticals, Mundipharma International Limited, Lupin Limited, Glenmark Pharmaceuticals Limited, Hetero Drugs Limited, Alembic Pharmaceuticals Limited, Sunovion Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc., Beximco Pharmaceuticals Ltd, Innoviva Inc., Vectura Group, Circassia Group PLC, Pulmatrix Inc., Atopix Therapeutics Limited

What Are The Key Trends Of The Global Asthma Drugs Market? Glenmark Launches Indamet FDC Drug For Uncontrolled Asthma Treatment

Major companies operating in the asthma drugs market are focusing on advancing innovations, such as fixed-dose combination (FDC) drugs, to enhance treatment efficacy and patient adherence. A fixed-dose combination (FDC) drug refers to a medication that contains two or more active ingredients combined in a single dosage form, such as a tablet, capsule, or inhaler. For instance, in June 2022, Glenmark Pharmaceuticals, an India-based pharmaceutical company, launched Indamet, a fixed-dose combination (FDC) drug in India for patients with uncontrolled asthma. This innovative treatment combines Indacaterol, a long-acting beta-agonist, with Mometasone Furoate, an inhaled corticosteroid, and is available in various strengths, including Indacaterol 150 mcg with Mometasone at 80 mcg, 160 mcg, and 320 mcg. Designed for once-daily administration, Indamet targets adults and adolescents aged 12 years and older.

What Are The Key Trends Of The Global Asthma Drugs Market? Product Innovation In The Asthma Drug Market With Launch Of Indacaterol Plus Mometasone

Major companies operating in the asthma drug market are focused on product innovation, such as indacaterol plus mometasone, to help in the management of uncontrolled asthma by improving lung function, better symptom control, and reducing exacerbations. Indacaterol plus Mometasone is a fixed-dose combination medication for the treatment of asthma in adults and adolescents twelve years of age and older that is not adequately controlled with inhaled corticosteroids and inhaled short-acting beta2 agonists. For instance, in June 2022, Glenmark Pharmaceuticals Limited, an India-based pharmaceutical company, launched a novel fixed-dose combination (FDC) drug, Indacaterol plus Mometasone, for patients suffering from uncontrolled asthma in India. The drug is marketed under the brand name Indamet and is the first of its kind in India, offering a world-class and affordable treatment option to both adults and adolescents 12 years of age and older suffering from uncontrolled asthma.

Need data on a specific region in this market?

Request Regional Data

Asthma Drugs Market Merger And Acquisition: Sandoz Boosts Respiratory Portfolio With Acquisition Of Coalesce Product Development

In March 2022, Sandoz, a Germany-based pharmaceutical company, completed the acquisition of Coalesce Product Development Limited for an undisclosed amount. This acquisition was part of Sandoz's strategy to expand its respiratory division's portfolio and strengthen its position as a global leader in respiratory products. Coalesce Product Development Limited is a UK-based drug delivery device development company with a broad portfolio of products such as pressurized metered-dose inhalers, breath-actuated inhalers, pre-metered dry powder inhalers, and others.

Regional Outlook For The Global Asthma Drugs Market

North America was the largest region in the asthma drugs market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Asthma Drugs Market?

The asthma drugs market consists of sales of drugs such as bronchodilators (beta-2 agonists), monoclonal antibodies (omalizumab, mepolizumab), and anti-inflammatory drugs (budesonide, ciclesonide), used for the treatment of asthma in patients of all ages. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Asthma Drugs Industry?

The asthma drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the asthma drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Asthma Drugs Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$24.93 billion
Revenue Forecast In 2034	$31.38 billion
Growth Rate	CAGR of 5.9% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Type Of Asthma: Allergic, Non-Allergic 2) By Asthma Trigger Type: Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma 3) By Therapy: Preventive, Curative 4) By Drug Class: Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs 5) By End-User: Asthma Patients, COPD Patients Subsegments: 1) By Allergic: Inhaled Corticosteroids (ICS), Leukotriene Receptor Antagonists (LTRAs), Monoclonal Antibodies 2) By Non-Allergic: Short-Acting Beta Agonists (SABAs), Long-Acting Beta Agonists (LABAs), Oral Corticosteroids
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC., GlaxoSmithKline PLC., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Novartis International AG, Mylan N.V., Cipla Limited, Chiesi Farmaceutici S.p.A., Sun Pharmaceutical Industries Limited, Hikma Pharmaceuticals, Mundipharma International Limited, Lupin Limited, Glenmark Pharmaceuticals Limited, Hetero Drugs Limited, Alembic Pharmaceuticals Limited, Sunovion Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc., Beximco Pharmaceuticals Ltd, Innoviva Inc., Vectura Group, Circassia Group PLC, Pulmatrix Inc., Atopix Therapeutics Limited
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Asthma Drugs Market Characteristics

3. Asthma Drugs Market Trends And Strategies

4. Asthma Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Asthma Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Asthma Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Asthma Drugs Market Growth Rate Analysis

5.4. Global Asthma Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Asthma Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Asthma Drugs Total Addressable Market (TAM)

6. Asthma Drugs Market Segmentation

6.1. Global Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Allergic

Non-Allergic

6.2. Global Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Adult-Onset Asthma

Child-Onset Asthma

Cough-Induced Asthma

Exercise-Induced Asthma

Occupational Asthma

Nocturnal Asthma

Steroid-Resistant Asthma

6.3. Global Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Preventive

Curative

6.4. Global Asthma Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Bronchodilators

Monoclonal Antibodies

Anti-Inflammatory Drugs

Combination Drugs

6.5. Global Asthma Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Asthma Patients

COPD Patients

6.6. Global Asthma Drugs Market, Sub-Segmentation Of Allergic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Inhaled Corticosteroids (ICS)

Leukotriene Receptor Antagonists (LTRAs)

Monoclonal Antibodies

6.7. Global Asthma Drugs Market, Sub-Segmentation Of Non-Allergic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Short-Acting Beta Agonists (SABAs)

Long-Acting Beta Agonists (LABAs)

Oral Corticosteroids

7. Asthma Drugs Market Regional And Country Analysis

7.1. Global Asthma Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Asthma Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Asthma Drugs Market

8.1. Asia-Pacific Asthma Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Asthma Drugs Market

9.1. China Asthma Drugs Market Overview

9.2. China Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Asthma Drugs Market

10.1. India Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Asthma Drugs Market

11.1. Japan Asthma Drugs Market Overview

11.2. Japan Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Asthma Drugs Market

12.1. Australia Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Asthma Drugs Market

13.1. Indonesia Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Asthma Drugs Market

14.1. South Korea Asthma Drugs Market Overview

14.2. South Korea Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Asthma Drugs Market

15.1. Western Europe Asthma Drugs Market Overview

15.2. Western Europe Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Asthma Drugs Market

16.1. UK Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Asthma Drugs Market

17.1. Germany Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Asthma Drugs Market

18.1. France Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Asthma Drugs Market

19.1. Italy Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Asthma Drugs Market

20.1. Spain Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Asthma Drugs Market

21.1. Eastern Europe Asthma Drugs Market Overview

21.2. Eastern Europe Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Asthma Drugs Market

22.1. Russia Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Asthma Drugs Market

23.1. North America Asthma Drugs Market Overview

23.2. North America Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Asthma Drugs Market

24.1. USA Asthma Drugs Market Overview

24.2. USA Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Asthma Drugs Market

25.1. Canada Asthma Drugs Market Overview

25.2. Canada Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Asthma Drugs Market

26.1. South America Asthma Drugs Market Overview

26.2. South America Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Asthma Drugs Market

27.1. Brazil Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Asthma Drugs Market

28.1. Middle East Asthma Drugs Market Overview

28.2. Middle East Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Asthma Drugs Market

29.1. Africa Asthma Drugs Market Overview

29.2. Africa Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Asthma Drugs Market Competitive Landscape And Company Profiles

30.1. Asthma Drugs Market Competitive Landscape

30.2. Asthma Drugs Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Asthma Drugs Market Other Major And Innovative Companies

31.1. AstraZeneca PLC.

31.2. GlaxoSmithKline PLC.

31.3. Boehringer Ingelheim International GmbH

31.4. Teva Pharmaceutical Industries Ltd.

31.5. Novartis International AG

31.6. Mylan N.V.

31.7. Cipla Limited

31.8. Chiesi Farmaceutici S.p.A.

31.9. Sun Pharmaceutical Industries Limited

31.10. Hikma Pharmaceuticals

31.11. Mundipharma International Limited

31.12. Lupin Limited

31.13. Glenmark Pharmaceuticals Limited

31.14. Hetero Drugs Limited

31.15. Alembic Pharmaceuticals Limited

32. Global Asthma Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Asthma Drugs Market

34. Recent Developments In The Asthma Drugs Market

35. Asthma Drugs Market High Potential Countries, Segments and Strategies

35.1 Asthma Drugs Market In 2029 - Countries Offering Most New Opportunities

35.2 Asthma Drugs Market In 2029 - Segments Offering Most New Opportunities

35.3 Asthma Drugs Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Asthma Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Asthma Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Asthma Drugs Market, Sub-Segmentation Of Allergic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Asthma Drugs Market, Sub-Segmentation Of Non-Allergic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Asthma Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Asthma Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Pfizer Inc. Financial Performance

Table 79: Roche Holding AG Financial Performance

Table 80: Merck & Co. Inc. Financial Performance

Table 81: Bayer AG Financial Performance

Table 82: Sanofi S.A. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Asthma Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Asthma Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Asthma Drugs Market, Sub-Segmentation Of Allergic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Asthma Drugs Market, Sub-Segmentation Of Non-Allergic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Asthma Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Asthma Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Pfizer Inc. Financial Performance

Figure 79: Roche Holding AG Financial Performance

Figure 80: Merck & Co. Inc. Financial Performance

Figure 81: Bayer AG Financial Performance

Figure 82: Sanofi S.A. Financial Performance

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the MSI-H and DMMR Market with 2025 insights from The Business Research Company.

Inhalable Drugs Global Market Report 2025 – By Product (Aerosol, Dry Powder Formulation, Spray), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Other Distribution Channels), By Application (Respiratory Dise...

Allergic Rhinitis Drugs Global Market Report 2025 – By Disease (Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis), By Treatment (Antihistamines, Immunotherapy, Corticosteroids, Deco...

Asthma Spacers Global Market Report 2025 – By Product (Aerochamber, Optichamber, Volumatic, Inspirease, Other Products), By Distribution Channels (E-commerce Channels, Retail Pharmacies, Hospital Pharmacies, Other Distri...

Inhalation And Nasal Spray Generic Drugs Global Market Report 2025 – By Drug Class( Corticosteroids, Bronchodilators, Antihistamines, Combinations, Decongestant Sprays), By Indication( Asthma, Chronic Obstructive Pulmona...

Asthma Drugs Global Market Report 2025 – By Type Of Asthma (Allergic, Non-Allergic), By Asthma Trigger Type (Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Noc...

Anti-Asthmatic And COPD Drugs Market 2021 - By Drug Class (Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs), By End User (Asthma Patients, COPD Patients), By Distribution Channel (Gener...

Frequently Asked Questions

What is the definition of the Asthma Drugs market?

How will the Asthma Drugs market drivers and restraints affect the market dynamics? What forces will shape the Asthma Drugs industry going forward?

The market major growth driver - Soaring Prevalence Of Asthmatic Disorders Propels Growth In The Asthma Drug Market. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Asthma Drugs market?

The asthma drugs market size has grown steadily in recent years. It will grow from $23.96 billion in 2024 to $24.93 billion in 2025 at a compound annual growth rate (CAGR) of 4.0%. The growth in the historic period can be attributed to environmental factors, increased respiratory disorders, lifestyle changes, healthcare infrastructure development The asthma drugs market size is expected to see strong growth in the next few years. It will grow to " $31.38 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to rising air pollution levels, growing aging population, increasing healthcare awareness, personalized medicine trends, biopharmaceutical innovations. Major trends in the forecast period include small molecule therapies, home-based asthma care, biomarker-guided therapies, therapeutic advances in severe asthma, collaborations for asthma research. For further insights on this market, request a sample here

How is the Asthma Drugs market segmented?

The asthma drugs market covered in this report is segmented –
1) By Type Of Asthma: Allergic, Non-Allergic
2) By Asthma Trigger Type: Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma
3) By Therapy: Preventive, Curative
4) By Drug Class: Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs
5) By End-User: Asthma Patients, COPD Patients Subsegments:
1) By Allergic: Inhaled Corticosteroids (ICS), Leukotriene Receptor Antagonists (LTRAs), Monoclonal Antibodies
2) By Non-Allergic: Short-Acting Beta Agonists (SABAs), Long-Acting Beta Agonists (LABAs), Oral Corticosteroids For further insights on this market, request a sample here

Which region has the largest share of the Asthma Drugs market? What are the other regions covered in the report?

North America was the largest region in the asthma drugs market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Asthma Drugs market?

What are the key trends in the Asthma Drugs market?

Major trends in this market include Glenmark Launches Indamet FDC Drug For Uncontrolled Asthma Treatment. For further insights on this market, request a sample here.